OC17.02: Adherence to guideline‐recommended aspirin for pre‐eclampsia prevention in Denmark.

This article, titled "OC17.02: Adherence to guideline-recommended aspirin for pre-eclampsia prevention in Denmark," examines the adherence of physicians in Denmark to guidelines regarding the prescription of aspirin to women at high risk for pre-eclampsia. The study, conducted among pregnant women enrolled in the PRESIDE study, found that only 41% of high-risk women eligible for low-dose aspirin treatment were actually prescribed aspirin. Women with previous pre-eclampsia were less likely to receive aspirin compared to those with other high-risk factors. The study suggests that the current screening approach for prescribing aspirin to high-risk women may be relatively low. [Extracted from the article]